GS0051: Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain
D10000: "PHARMACEUTICALS"
GS0421: Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
Case File Event Statements
7/19/2022 - 3 years ago
44 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
7/19/2022 - 3 years ago
43 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
1/5/2022 - 3 years ago
42 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
1/5/2022 - 3 years ago
41 - NON-FINAL ACTION E-MAILEDType:GNRT
1/5/2022 - 3 years ago
40 - SU - NON-FINAL ACTION - WRITTENType:CNRT
11/30/2021 - 3 years ago
39 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
10/29/2021 - 4 years ago
38 - USE AMENDMENT FILEDType:IUAF
10/29/2021 - 4 years ago
37 - TEAS STATEMENT OF USE RECEIVEDType:EISU
5/8/2021 - 4 years ago
36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
5/7/2021 - 4 years ago
35 - SOU EXTENSION 5 GRANTEDType:EX5G
4/29/2021 - 4 years ago
34 - SOU EXTENSION 5 FILEDType:EXT5
5/7/2021 - 4 years ago
33 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
4/29/2021 - 4 years ago
32 - SOU TEAS EXTENSION RECEIVEDType:EEXT
10/30/2020 - 5 years ago
31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
10/28/2020 - 5 years ago
30 - SOU EXTENSION 4 GRANTEDType:EX4G
10/28/2020 - 5 years ago
29 - SOU EXTENSION 4 FILEDType:EXT4
10/28/2020 - 5 years ago
28 - SOU TEAS EXTENSION RECEIVEDType:EEXT
4/28/2020 - 5 years ago
27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
4/24/2020 - 5 years ago
26 - SOU EXTENSION 3 GRANTEDType:EX3G
4/24/2020 - 5 years ago
25 - SOU EXTENSION 3 FILEDType:EXT3
4/24/2020 - 5 years ago
24 - SOU TEAS EXTENSION RECEIVEDType:EEXT
10/23/2019 - 6 years ago
23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
10/21/2019 - 6 years ago
22 - SOU EXTENSION 2 GRANTEDType:EX2G
10/21/2019 - 6 years ago
21 - SOU EXTENSION 2 FILEDType:EXT2
10/21/2019 - 6 years ago
20 - SOU TEAS EXTENSION RECEIVEDType:EEXT
4/19/2019 - 6 years ago
19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA